NO974322D0 - DNA som koder for human papillomvirus type 18 - Google Patents

DNA som koder for human papillomvirus type 18

Info

Publication number
NO974322D0
NO974322D0 NO974322A NO974322A NO974322D0 NO 974322 D0 NO974322 D0 NO 974322D0 NO 974322 A NO974322 A NO 974322A NO 974322 A NO974322 A NO 974322A NO 974322 D0 NO974322 D0 NO 974322D0
Authority
NO
Norway
Prior art keywords
dna encoding
encoding human
human papillomavirus
papillomavirus type
type
Prior art date
Application number
NO974322A
Other languages
English (en)
Other versions
NO322254B1 (no
NO974322L (no
Inventor
Kathryn J Hofmann
Kathrin U Jansen
Michael P Neeper
Joseph G Joyce
Hugh A George
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974322(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/409,122 external-priority patent/US5820870A/en
Priority claimed from US08/408,669 external-priority patent/US5840306A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO974322D0 publication Critical patent/NO974322D0/no
Publication of NO974322L publication Critical patent/NO974322L/no
Publication of NO322254B1 publication Critical patent/NO322254B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/58—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi
    • C12N9/60—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from fungi from yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19974322A 1995-03-22 1997-09-19 Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette. NO322254B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/409,122 US5820870A (en) 1995-03-22 1995-03-22 Recombinant human papillomavirus type 18 vaccine
US08/408,669 US5840306A (en) 1995-03-22 1995-03-22 DNA encoding human papillomavirus type 18
PCT/US1996/003649 WO1996029413A2 (en) 1995-03-22 1996-03-18 Dna encoding human papilloma virus type 18

Publications (3)

Publication Number Publication Date
NO974322D0 true NO974322D0 (no) 1997-09-19
NO974322L NO974322L (no) 1997-11-24
NO322254B1 NO322254B1 (no) 2006-09-04

Family

ID=27020342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974322A NO322254B1 (no) 1995-03-22 1997-09-19 Virusliknende partikler samt fremgangsmate for fremstilling av disse, rekombinant papillomavirusantigen, vaksine,isolert og renset HPV18L1-DNA-molekeyl og anvendelse av dette.

Country Status (22)

Country Link
EP (2) EP1422294A1 (no)
JP (1) JPH11502704A (no)
KR (1) KR100430698B1 (no)
CN (1) CN1100876C (no)
AT (1) ATE259879T1 (no)
AU (1) AU714533B2 (no)
CA (1) CA2215834C (no)
CZ (1) CZ291242B6 (no)
DE (4) DE122007000031I1 (no)
DK (1) DK0817851T5 (no)
EA (1) EA001092B1 (no)
ES (1) ES2213772T3 (no)
FR (1) FR07C0023I2 (no)
HU (1) HU223761B1 (no)
IL (1) IL117459A (no)
NL (3) NL300272I1 (no)
NO (1) NO322254B1 (no)
NZ (1) NZ305188A (no)
PL (1) PL184022B1 (no)
PT (1) PT817851E (no)
SK (1) SK284281B6 (no)
WO (1) WO1996029413A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
ZA982950B (en) 1997-04-08 1998-10-19 Merck & Co Inc Stabilized human papillomavirus formulations
CA2286294A1 (en) * 1997-04-08 1998-10-15 Merck & Co., Inc. Stabilized human papillomavirus formulations
CN1354787A (zh) * 1998-08-14 2002-06-19 麦克公司 纯化人乳头瘤病毒样颗粒的方法
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
SI1150712T1 (sl) 1999-02-05 2009-02-28 Merck & Co Inc Pripravek cepiva proti humanem papiloma virusu
FR2795074A1 (fr) * 1999-05-21 2000-12-22 Inst Nat Sante Rech Med Polypeptides transporteurs d'acides amines, et en particulier du glutamate, et procedes de criblage de composes inhibiteurs ou activateurs de l'activite de transport
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
US9428555B2 (en) 2007-04-29 2016-08-30 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated L1 protein of Human Papillomavirus type 16
US9364529B2 (en) 2007-04-29 2016-06-14 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Truncated L1 protein of human papillomavirus type 18
CN101440373B (zh) * 2007-11-23 2012-09-05 上海泽润生物科技有限公司 一种截短型的18型人乳头状瘤病毒主要衣壳蛋白l1基因
EP2445525A2 (en) * 2009-06-25 2012-05-02 GlaxoSmithKline Biologicals S.A. Novel human papillomavirus (hpv) protein constructs and their use in the prevention of hpv disease
BR112013032338B1 (pt) * 2011-06-15 2021-04-20 Posvax Co., Ltd método para melhorar o rendimento de produção para proteína l1 do papilomavírus humano
US20150110824A1 (en) 2012-03-18 2015-04-23 Glaxosmithkline Biologicals, Sa Method of vaccination against human papillomavirus
CN108276491B (zh) * 2018-02-05 2021-01-12 南京薇熙生物医药科技有限公司 一种可特异性识别hpv18 l1蛋白的单克隆抗体及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625257A1 (de) * 1986-07-23 1988-02-04 Behringwerke Ag Expressionsprodukte der menschlichen papillomviren typ 16 und 18, fuer diese proteine spezifische antikoerper und diese antikoerper bzw. entsprechende dna enthaltende diagnostika
DE4015044A1 (de) * 1990-05-10 1991-11-14 Behringwerke Ag Seroreaktive epitope auf proteinen des menschlichen papillomavirus (hpv) 18
SG48769A1 (en) * 1991-07-19 1998-05-18 Univ Queensland Papilloma virus vaccine
DE122007000099I1 (de) * 1992-06-25 2008-03-27 Papillomavirus vakzine
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
ES2263406T3 (es) * 1993-03-09 2011-06-06 The University Of Rochester Producción de la proteína de capside l1 del papilomavirus humano hpv-11 y partículas de tipo virus.

Also Published As

Publication number Publication date
DE122007000025I1 (de) 2007-07-12
CZ291242B6 (cs) 2003-01-15
NZ305188A (en) 1999-11-29
IL117459A (en) 2005-11-20
HU223761B1 (hu) 2005-01-28
CN1185176A (zh) 1998-06-17
FR07C0023I2 (fr) 2012-08-03
NL300273I1 (nl) 2007-05-01
MX9707208A (es) 1997-11-29
HUP9801334A3 (en) 1999-04-28
EP0817851A2 (en) 1998-01-14
DE122007000031I1 (de) 2007-07-19
NL300272I1 (nl) 2007-05-01
NL300271I1 (nl) 2007-05-01
DE122007000030I1 (de) 2007-07-19
WO1996029413A3 (en) 1996-11-28
EA001092B1 (ru) 2000-10-30
DK0817851T3 (da) 2004-08-16
EP0817851B1 (en) 2004-02-18
DE69631586T9 (de) 2005-06-16
CN1100876C (zh) 2003-02-05
PT817851E (pt) 2004-06-30
CA2215834A1 (en) 1996-09-26
DK0817851T5 (da) 2004-10-25
ATE259879T1 (de) 2004-03-15
KR100430698B1 (ko) 2004-07-15
EP0817851B9 (en) 2004-08-18
ES2213772T3 (es) 2004-09-01
EP1422294A1 (en) 2004-05-26
SK284281B6 (sk) 2004-12-01
JPH11502704A (ja) 1999-03-09
NO322254B1 (no) 2006-09-04
DE69631586D1 (de) 2004-03-25
NO974322L (no) 1997-11-24
AU5314196A (en) 1996-10-08
DE69631586T2 (de) 2005-01-27
HUP9801334A2 (hu) 1998-08-28
WO1996029413A2 (en) 1996-09-26
CA2215834C (en) 2007-06-12
EA199700256A1 (ru) 1999-06-24
PL184022B1 (pl) 2002-08-30
CZ293697A3 (cs) 1998-02-18
IL117459A0 (en) 1996-07-23
SK127897A3 (en) 1998-07-08
PL322333A1 (en) 1998-01-19
AU714533B2 (en) 2000-01-06
FR07C0023I1 (no) 2007-04-27

Similar Documents

Publication Publication Date Title
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
TR199600084A2 (tr) Sismanlamaya karsi proteinler.
BG100974A (en) Vaccines against papillomavirus
EE03472B1 (et) Ravimvormid inimese seksuaalreaktsiooni moduleerimiseks
NO971875L (no) Cathepsin 02 protease
DE68929467D1 (de) HIV-2 Varianten
NO965084D0 (no) N-[3(3-cyanopyrazol[1,5-aÅpyrimidin-7-yl)fenylÅ-N-etyl-acetamid
MA23778A1 (fr) Purine-6-ones-2,9 disubstituees
NO971347D0 (no) DNA som koder for humant papillomvirus type 6A
FI972030A (fi) Puhdistettuja papillomavirusproteiineja
DK0990703T3 (da) Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf
TR199600932T1 (tr) Yeni peptidlerin bagisiklik düzenleyici (immünomodülatör)etkileri.
SE9602822D0 (sv) New receptor
TR199501328A2 (tr) Alzheimer peptidi.
ES2073495T3 (es) Benzotiazepinas.
ES2191785T3 (es) Proteina de accion antitumoral.
SE9604439D0 (sv) New receptor
FR2727965B1 (fr) 4,4'-(phenylenediisopropyl )-bis- (2.6-dialkylphenylisocyanates)
IT1295973B1 (it) Procedimento per l'illuminazione di oggetti.
TR199801087T2 (xx) 4,10 �- diasetoksi-2alfa-Benzoiloksi- 5 �, 20 epoksi-1- hidroksi-9- okso-19- norsiklopropa(G) taks-11- en- 13alfa-il
KR950024792U (ko) 차량용 엘. 피. 지 캡(l. p. g cap)
FR2719994B1 (fr) Béquilles.
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ITRM940330A0 (it) "procedimento migliorato per la preparazione della 14b-idrossi-etianaldeide".
TR199600085A2 (tr) Sismanlamaya karsi proteinler.

Legal Events

Date Code Title Description
MK1K Patent expired